Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 16869

1.

Malignant Peritoneal Mesothelioma in an Infant With Familial ATM Mutations.

Mijalovsky A, Halperin D, Perez Y, Zafarov B, Shaco-Levy R, Kapelushnik J, Flusser H, Birk OS.

J Pediatr Hematol Oncol. 2018 Aug 17. doi: 10.1097/MPH.0000000000001294. [Epub ahead of print]

PMID:
30124550
2.

Personalized treatment of malignant mesothelioma-dream or reality?

Roden AC.

J Thorac Dis. 2018 Jul;10(Suppl 18):S2153-S2156. doi: 10.21037/jtd.2018.06.67. No abstract available.

PMID:
30123547
3.

5-hydroxymethylcytosine but not MTAP methylation status can stratify malignant pleural mesothelioma based on the lineage of origin.

Bosio M, Salvaterra E, Datturi F, Morbini P, Zorzetto M, Inghilleri S, Tomaselli S, Mangiarotti P, Meloni F, Cerveri I, Stella GM.

Multidiscip Respir Med. 2018 Aug 2;13:27. doi: 10.1186/s40248-018-0137-4. eCollection 2018.

PMID:
30123503
4.

State of the Art review - Surgery in Malignant Pleural Mesothelioma.

Bueno R, Opitz I; IASLC Mesothelioma Taskforce.

J Thorac Oncol. 2018 Aug 16. pii: S1556-0864(18)30937-7. doi: 10.1016/j.jtho.2018.08.001. [Epub ahead of print] Review.

PMID:
30121394
5.

Primary peritoneal Epithelioid mesothelioma of clear cell type with a novel VHL gene mutation: a case report.

Smith-Hannah A, Naous R.

Hum Pathol. 2018 Aug 14. pii: S0046-8177(18)30303-4. doi: 10.1016/j.humpath.2018.07.033. [Epub ahead of print]

PMID:
30118736
6.

Idiopathic chronic hematocele mimicking a mesothelioma of the tunica vaginalis testis.

Bibi M, Sellami A, Taktak T, Kassar AZ, Chehida MAB, Chaker K, Abid K, Rhouma SB, Nouira Y.

Urol Case Rep. 2018 Aug 1;20:104-105. doi: 10.1016/j.eucr.2018.07.022. eCollection 2018 Sep. No abstract available.

7.

Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma.

Panou V, Gadiraju M, Wolin A, Weipert CM, Skarda E, Husain AN, Patel JD, Rose B, Zhang SR, Weatherly M, Nelakuditi V, Knight Johnson A, Helgeson M, Fischer D, Desai A, Sulai N, Ritterhouse L, Røe OD, Turaga KK, Huo D, Segal J, Kadri S, Li Z, Kindler HL, Churpek JE.

J Clin Oncol. 2018 Aug 16:JCO2018785204. doi: 10.1200/JCO.2018.78.5204. [Epub ahead of print]

PMID:
30113886
8.

Inhibition of MDM2 via Nutlin-3A: A Potential Therapeutic Approach for Pleural Mesotheliomas with MDM2-Induced Inactivation of Wild-Type P53.

Walter RFH, Werner R, Wessolly M, Mairinger E, Borchert S, Schmeller J, Kollmeier J, Mairinger T, Hager T, Bankfalvi A, Christoph DC, Eberhardt WEE, Plönes T, Aigner C, Schmid KW, Wohlschlaeger J, Mairinger FD.

J Oncol. 2018 Jul 17;2018:1986982. doi: 10.1155/2018/1986982. eCollection 2018.

9.

Hypoxia promotes acquisition of aggressive phenotypes in human malignant mesothelioma.

Kim MC, Hwang SH, Kim NY, Lee HS, Ji S, Yang Y, Kim Y.

BMC Cancer. 2018 Aug 15;18(1):819. doi: 10.1186/s12885-018-4720-z.

10.

First case report of malignant peritoneal mesothelioma and oral verrucous carcinoma in a patient with a germline PTEN mutation: a combination of extremely rare diseases with probable further implications.

Löffler MW, Steinhilber J, Hilke FJ, Haen SP, Bösmüller H, Montes-Mojarro IA, Bonzheim I, Stäbler A, Faust U, Grasshoff U, Königsrainer I, Rammensee HG, Kanz L, Königsrainer A, Beckert S, Riess O, Schroeder C.

BMC Med Genet. 2018 Aug 15;19(1):144. doi: 10.1186/s12881-018-0651-4.

11.

Malignant Pleural Mesothelioma, Biphasic Type: An Unusual and Insidious Case of Rapidly Progressive Small Blue Cell Tumor.

Salazar C, Kanter Md N, Abboud A.

Cureus. 2018 Jun 6;10(6):e2749. doi: 10.7759/cureus.2749.

12.

Asbestos Exposure and the Mesothelioma Incidence in Poland.

Krówczyńska M, Wilk E.

Int J Environ Res Public Health. 2018 Aug 13;15(8). pii: E1741. doi: 10.3390/ijerph15081741.

13.

Double cancer comprising malignant pleural mesothelioma and squamous cell carcinoma of the lung treated with radiotherapy: A case report.

Negi Y, Kuribayashi K, Doi H, Funaguchi N, Koda Y, Fujimoto E, Mikami K, Minami T, Yokoi T, Kijima T.

Mol Clin Oncol. 2018 Aug;9(2):181-186. doi: 10.3892/mco.2018.1650. Epub 2018 Jun 11.

14.

Treatment of recurrent isolated right atrial metastatic cavitary mass from breast cancer with radiation therapy: A case report and review of literature.

Ya'qoub L, Larson S, Deedy M, Saeed IM.

Echocardiography. 2018 Aug 12. doi: 10.1111/echo.14120. [Epub ahead of print]

PMID:
30099774
15.

Intraoperative fluorescence imaging in thoracic surgery.

Newton AD, Predina JD, Nie S, Low PS, Singhal S.

J Surg Oncol. 2018 Aug 11. doi: 10.1002/jso.25149. [Epub ahead of print] Review.

PMID:
30098293
16.

Measurement of telomere length in cells from pleural effusion: Asbestos exposure causes telomere shortening in pleural mesothelial cells.

Aida S, Aida J, Naoi M, Kato M, Tsuura Y, Natsume I, Takubo K.

Pathol Int. 2018 Aug 10. doi: 10.1111/pin.12710. [Epub ahead of print]

PMID:
30098092
17.

Malignant Mesothelioma Treatment (PDQ®): Health Professional Version.

PDQ Adult Treatment Editorial Board.

PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-.
2018 Jul 27.

18.

Malignant Mesothelioma Treatment (PDQ®): Patient Version.

PDQ Adult Treatment Editorial Board.

PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-.
2018 Jul 30.

19.

Video-Thoracoscopic Management of Postpneumonectomy Empyema.

Galetta D, Spaggiari L.

Thorac Cardiovasc Surg. 2018 Aug 7. doi: 10.1055/s-0038-1667008. [Epub ahead of print]

PMID:
30086571
20.

Miracle mineral or mesothelioma: cancer and asbestos in the USA.

Lucas C.

Lancet Oncol. 2018 Jul;19(7):868. doi: 10.1016/S1470-2045(18)30352-8. Epub 2018 Jun 29. No abstract available.

PMID:
30084369

Supplemental Content

Loading ...
Support Center